Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0007758
Disease: Cerebellar Ataxia
Cerebellar Ataxia
0.070 GeneticVariation phenotype BEFREE In humans, genetic mutations in the PMCA2 gene in association with cadherin 23 mutations have been linked to hearing loss phenotypes, while those occurring in the PMCA3 gene were associated with X-linked congenital cerebellar ataxias. 29655659 2018
CUI: C0007758
Disease: Cerebellar Ataxia
Cerebellar Ataxia
0.070 GeneticVariation phenotype BEFREE PMCA 2 mutations are associated with deafness and PMCA 3 mutations are linked to cerebellar ataxias. 29155350 2018
CUI: C0007758
Disease: Cerebellar Ataxia
Cerebellar Ataxia
0.070 GeneticVariation phenotype BEFREE The findings highlight the association of PMCA3 mutations to cerebellar ataxia and strengthen the possibility that PMCAs act as digenic modulators in Ca<sup>2+</sup>-linked pathologies. 28807751 2017
CUI: C0007758
Disease: Cerebellar Ataxia
Cerebellar Ataxia
0.070 GeneticVariation phenotype BEFREE Because Atp2b3 mutation leads to congenital ataxia in humans, the identified Atp2b3 missense change in the shaker rat presents a good candidate for the shaker rat phenotype based on genetic criteria, but cannot yet be considered a definite pathogenic variant owing to lack of functional changes. 27013529 2016
CUI: C0007758
Disease: Cerebellar Ataxia
Cerebellar Ataxia
0.070 GeneticVariation phenotype BEFREE Here we describe a novel mutation in the ATP2B3 gene in a patient with global developmental delay, generalized hypotonia and cerebellar ataxia. 25953895 2015
CUI: C0007758
Disease: Cerebellar Ataxia
Cerebellar Ataxia
0.070 GeneticVariation phenotype BEFREE A cerebellar X-linked human ataxia has recently been found to be caused by a mutation in the calmodulin-binding domain of PMCA3. 23413890 2013
CUI: C0007758
Disease: Cerebellar Ataxia
Cerebellar Ataxia
0.070 Biomarker phenotype BEFREE This case report describes a patient with OPCA with cerebellar ataxia as the presenting and most prominent feature in combination with dementia, pyramidal signs, cortical cataract of the posterior pole and a raised IgG index in cerebrospinal fluid. 9213052 1997